{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06138639",
            "orgStudyIdInfo": {
                "id": "SGT-003-101"
            },
            "organization": {
                "fullName": "Solid Biosciences Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)",
            "officialTitle": "A Phase 1/2, Multicenter, Open-Label Study to Investigate the Safety, Tolerability, and Efficacy of a Single Intravenous Dose of SGT-003 in Ambulant Males With Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-of-sgt-gene-therapy-in-duchenne-muscular-dystrophy-inspire-duchenne"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-06",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-05-06",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-05-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-14",
            "studyFirstSubmitQcDate": "2023-11-14",
            "studyFirstPostDateStruct": {
                "date": "2023-11-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-08",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-10",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Solid Biosciences Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This is a multicenter, open-label, non-randomized study to investigate the safety, tolerability, and efficacy of a single IV infusion of SGT-003 in participants with Duchenne muscular dystrophy. There will be 2 cohorts in this study. Cohort 1 will include participants 4 to \\<6 years of age, inclusive. Cohort 2 will include participants 6 to \\<8 years of age, inclusive. All participants will receive SGT-003 and will be enrolled in the study for 5 total years for long-term follow up."
        },
        "conditionsModule": {
            "conditions": [
                "Duchenne Muscular Dystrophy"
            ],
            "keywords": [
                "DMD",
                "Gene Therapy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 6,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort 1: SGT-003",
                    "type": "EXPERIMENTAL",
                    "description": "All participants will receive a single IV infusion of SGT-003 on Day 1.",
                    "interventionNames": [
                        "Genetic: SGT-003"
                    ]
                },
                {
                    "label": "Cohort 2: SGT-003",
                    "type": "EXPERIMENTAL",
                    "description": "All participants will receive a single IV infusion of SGT-003 on Day 1.",
                    "interventionNames": [
                        "Genetic: SGT-003"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "GENETIC",
                    "name": "SGT-003",
                    "description": "Adeno-associated virus serotype SLB101 containing the human microdystrophin gene (h-\u00b5D5)",
                    "armGroupLabels": [
                        "Cohort 1: SGT-003",
                        "Cohort 2: SGT-003"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of treatment-emergent adverse events (AEs)",
                    "timeFrame": "Day 360"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from baseline in microdystrophin protein levels",
                    "description": "Microdystrophin expression evaluation in muscle biopsies",
                    "timeFrame": "Day 90, Day 360"
                },
                {
                    "measure": "Change from baseline in North Star Ambulatory Assessment (NSAA) total score",
                    "description": "Assessment of muscle function using a 17-item scale with each item scored from 0 to 2 and a higher score meaning a better outcome. The NSAA total score is defined as the sum of all 17 items, ranging from 0 to 34, with a higher score meaning a better outcome.",
                    "timeFrame": "Day 360"
                },
                {
                    "measure": "Change from baseline in stride velocity 95th centile (SV95C)",
                    "description": "Assessment of peak ambulatory performance captured by wearable activity monitoring device",
                    "timeFrame": "Day 360"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Cohort 1: 4 to \\<6 years of age, inclusive\n* Cohort 2: 6 to \\<8 years of age, inclusive\n* Participants who are ambulatory. Ambulatory as defined as \"being able to walk without the use of an assistive device.\"\n* Established clinical diagnosis of DMD and documented dystrophin gene mutation predictive of DMD phenotype confirmed by Sponsor genetic testing.\n* Negative for AAV antibodies.\n* On a stable dose of at least 0.5 mg/kg/day of oral daily prednisone or 0.75 mg/kg/day deflazacort for \u226512 weeks prior to entering the study.\n* Participant has body weight:\n\n  * Cohort 1: \u226425 kg\n  * Cohort 2: \\<30 kg\n* Time to rise from supine of \\<5 seconds.\n\nExclusion Criteria:\n\n* Current or prior treatment with approved or investigational dystrophin modifying drugs such as eteplirsen, golodirsen, casimersen, and viltolarsen.\n* Current or prior treatment with an approved or investigational gene transfer drug.\n* Exposure to another investigational drug within 3 months prior to screening or 5 half-lives since last administration, whichever is longer.\n* Established clinical diagnosis of DMD that is associated with any deletion mutation in exons 1 to 11 or 42 to 45, inclusive, in the DMD gene as documented by a genetic report and confirmed by Sponsor genetic testing.\n\nOther inclusion or exclusion criteria apply.",
            "healthyVolunteers": false,
            "sex": "MALE",
            "genderBased": true,
            "minimumAge": "4 Years",
            "maximumAge": "7 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Solid Bio Clinical Trials",
                    "role": "CONTACT",
                    "phone": "617-337-4680",
                    "email": "clinicaltrials@solidbio.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Solid Bio Clinical Trials",
                    "affiliation": "Solid Biosciences",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California, Los Angeles Medical Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ummi Qasim",
                            "role": "CONTACT",
                            "phone": "310-825-3264",
                            "email": "UQasim@mednet.ucla.edu"
                        },
                        {
                            "name": "Perry Shieh, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Nationwide Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rox Ann Sullivan",
                            "role": "CONTACT",
                            "phone": "614-355-3635",
                            "email": "RoxAnn.Sullivan@nationwidechildrens.org"
                        },
                        {
                            "name": "Kevin Flanigan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009136",
                    "term": "Muscular Dystrophies"
                },
                {
                    "id": "D000020388",
                    "term": "Muscular Dystrophy, Duchenne"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020966",
                    "term": "Muscular Disorders, Atrophic"
                },
                {
                    "id": "D000009135",
                    "term": "Muscular Diseases"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000040181",
                    "term": "Genetic Diseases, X-Linked"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12093",
                    "name": "Muscular Dystrophies",
                    "asFound": "Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22185",
                    "name": "Muscular Dystrophy, Duchenne",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12092",
                    "name": "Muscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4589",
                    "name": "Atrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "M22697",
                    "name": "Muscular Disorders, Atrophic",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M24877",
                    "name": "Genetic Diseases, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "T3963",
                    "name": "Muscular Dystrophy",
                    "asFound": "Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T698",
                    "name": "Becker Muscular Dystrophy",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1945",
                    "name": "Duchenne Muscular Dystrophy",
                    "asFound": "Duchenne Muscular Dystrophy",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}